The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
about
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally.Development of a CRISPR-Cas9 System for Efficient Genome Editing of Candida lusitaniaeDrug development challenges and strategies to address emerging and resistant fungal pathogens.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida aurisCandida auris: a worrisome, globally emerging pathogen.Drugs currently under investigation for the treatment of invasive candidiasis.Antifungal resistance: current trends and future strategies to combat.Candida auris: An Emerging Fungal Pathogen.Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.Rare fungal infectious agents: a lurking enemy.In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris.New opportunities for managing acute and chronic lung infections.Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All.Candida auris: a Review of the Literature.CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.Candida-Epithelial Interactions.Containment strategies to address the expanding threat of multidrug-resistant Candida auris.Candida auris: Disinfectants and Implications for Infection Control.In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.First reported case of multidrug-resistant Candida auris in Canada.Peptide-Like Nylon-3 Polymers with Activity against Phylogenetically Diverse, Intrinsically Drug-Resistant Pathogenic Fungi.First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China.Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance.Epidemiology, clinical characteristics, resistance, and treatment of infections byResponding to the emergence of antifungal drug resistance: perspectives from the bench and the bedsideTreatment of Invasive Candidiasis: A Narrative ReviewEnfumafungin synthase represents a novel lineage of fungal triterpene cyclases
P2860
Q33704302-F64E3290-26F3-489C-B3A5-1E805E37C444Q33823084-64434F88-9EAE-4B2D-B776-80454E40CEB9Q38798805-F59B2891-B874-44C4-B185-B6E47596E4C5Q39092177-A0288FE6-A862-40D4-B62E-B19E23B9463CQ39092215-37EBD9AE-89F3-4A92-B89E-4889FDB5E2E7Q39092282-4DB90778-42F6-49E8-B829-BEEFE96F174BQ39375330-D1FFA36A-0236-46C5-9350-B41C82FDACCDQ41632930-CB7BDF90-5EB5-4039-8870-E5EDE6516451Q46255772-7574A7B8-01DA-4318-B243-C0A1D3E39D11Q46257698-2D1E23BA-B47E-40DA-9C79-B9DB07CC4C36Q46258749-AF121C1A-CFD1-4004-8021-28A0A8028B89Q47195606-E1274182-C949-4401-A13C-184F0D1CFF2CQ47734944-CE16F211-2807-415F-B0E8-9F78B8307F45Q48220845-F02D84E8-45FF-423E-93D9-C439B2894785Q49679927-1D767DCC-4EDB-4014-8F93-D845E42F20CDQ49988058-88E85C48-980A-44F7-BC36-6C114DB41E3FQ50042600-C651794F-67C8-4ABA-905A-61DC58FD3C55Q50065359-9B4C3F93-4360-4AE6-89AD-86B418DB9E28Q50117670-CC068B81-9115-42CC-BC8C-059471F9B53DQ50128552-CFEDF399-0D82-4AC2-BDBD-CC9FEFCD713DQ53690366-308DB826-7ED0-4BA8-B3EB-65A147D572CDQ53789385-1C43EB03-0B65-4867-9DE9-D07A2A0E91CFQ54957028-920878CA-DAFD-47CA-977B-085B1D78BDE5Q55017741-00E20816-C39B-47FD-B2B5-25E0F46E871DQ55334499-417115DC-14BE-4461-B2FC-8F8EDAEAAC36Q55547464-A1ED6C6F-8E01-4491-B356-A39536444514Q55689919-9D797324-1F82-4A83-B482-C20269B61ACFQ58598193-0F7F1290-536F-4A66-A3F1-D217218345D5Q58772251-CF1D9930-0ACF-4AB1-9F0B-89967F9E3D7FQ58772447-08C4AE97-2CD2-4F02-B680-CE197F99C6D1Q59137597-77246685-F6DD-44BB-964B-F56B60AE867E
P2860
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Emerging Pathogen Candida ...... phology and Biofilm Formation.
@en
type
label
The Emerging Pathogen Candida ...... phology and Biofilm Formation.
@en
prefLabel
The Emerging Pathogen Candida ...... phology and Biofilm Formation.
@en
P2093
P2860
P356
P1476
The Emerging Pathogen Candida ...... rphology and Biofilm Formation
@en
P2093
Christopher Hager
David Angulo
Iman Salem
Jyotsna Chandra
Katyna Borroto-Esoda
Mahmoud Ghannoum
Mauricio Retuerto
Nancy Isham
Pranab K Mukherjee
P2860
P356
10.1128/AAC.02396-16
P407
P577
2017-04-24T00:00:00Z